Welcome to our dedicated page for Cannae Holdings SEC filings (Ticker: CNNE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Cannae Holdings, Inc. (NYSE: CNNE), a Nevada-incorporated holding company that acquires and actively manages interests in operating businesses. Through these filings, readers can review how Cannae reports material events, portfolio transactions, governance changes, and financial information in its capacity as a public company.
Cannae’s current reports on Form 8-K illustrate several key aspects of its regulatory history. The company has used Form 8-K to disclose the completion of the disposition of all of its equity interests in Dun & Bradstreet Holdings, Inc., including the aggregate cash proceeds it received and the fact that it no longer holds any ownership interest in that company. Other 8-K filings cover the announcement of quarterly financial results and the furnishing of related press releases and letters to shareholders, which discuss results of operations and financial condition.
Filings also document important governance developments. Cannae reported shareholder approval of an amendment to its Articles of Incorporation to declassify its board of directors and the subsequent filing of Amended and Restated Articles of Incorporation and Amended and Restated Bylaws to implement the declassification. Another 8-K details the matters submitted to a vote at the 2025 annual meeting of shareholders, including director elections, an advisory vote on executive compensation, ratification of the independent auditor, approval of the declassification amendment, and a shareholder proposal.
By reviewing Cannae’s Forms 8-K, along with its annual and quarterly reports and proxy statements referenced in those filings, investors can see how the company describes its permanent capital model, portfolio actions, capital allocation decisions, and governance structure in official regulatory documents. AI-powered tools on this page can help summarize lengthy filings, highlight key items such as major asset dispositions, charter and bylaw amendments, and shareholder voting results, and make it easier to navigate CNNE’s SEC disclosure history.
Cannae Holdings, Inc. (CNNE)7,818 shares of common stock on November 12, 2025 at $0 per share as a restricted stock award. According to the footnote, the award vests in three equal annual installments beginning November 12, 2026. Following this transaction, the reporting person beneficially owns 34,279 shares with direct ownership.
Cannae Holdings (CNNE) reported an insider equity award on Form 4. A company director received 7,818 shares of common stock on 11/12/2025 at a reported price of $0, reflecting a standard restricted stock grant.
The award vests in three equal annual installments beginning November 12, 2026. Following this transaction, the director beneficially owns 11,785 shares, held directly. This filing indicates routine director compensation via restricted stock with a multi‑year vesting schedule.
Cannae Holdings (CNNE) reported a director equity grant. On
The award vests in three equal annual installments beginning
Cannae Holdings (CNNE) reported an insider equity award. A director acquired 7,818 shares of common stock at $0 on 11/12/2025, reflecting a restricted stock grant.
Following the transaction, the reporting person beneficially owns 143,942 shares held directly. The grant vests in three equal annual installments beginning November 12, 2026.
Cannae Holdings (CNNE) reported an insider equity award. A director acquired 7,818 shares of common stock on 11/12/2025 as an “A” code transaction, reflecting a grant priced at $0. Following this award, the reporting person beneficially owned 207,437 shares directly.
The grant is described as restricted stock that will vest in three equal annual installments beginning November 12, 2026. The filing also lists 0 shares held indirectly via the Frank and Marisa Martire 2012 Florida Trust after the reported transaction.
Cannae Holdings (CNNE) reported an insider equity award. A director acquired 7,818 shares of common stock on 11/12/2025 at a reported price of $0, reflecting a restricted stock grant. Following the transaction, the director’s beneficial ownership stands at 28,818 shares.
The award vests in three equal annual installments beginning November 12, 2026, aligning compensation with longer-term service. This filing documents the grant and updated holdings; it does not indicate any open-market purchase or sale.
Cannae Holdings (CNNE) reported an insider equity award. A director received a grant of 7,818 shares of restricted stock on November 12, 2025 at $0. The award vests in three equal annual installments beginning November 12, 2026.
Following the grant, the director beneficially owns 34,733 shares directly. Indirect holdings include 1,942 shares through Holland III Family LP and 8,058 shares through the Malcolm Holland IRA.
Cannae Holdings, Inc. (CNNE) reported an insider equity grant. A director acquired 7,818 shares of common stock on 11/12/2025 at $0, coded as an acquisition (A).
The filing notes this was a grant of restricted stock that vests in three equal annual installments beginning November 12, 2026. Following this transaction, the director beneficially owns 66,853 shares, held directly.
Cannae Holdings (CNNE): Form 4 insider equity grant. A director received 15,635 shares of common stock as a restricted stock award on 11/12/2025 at $0. The award vests in three equal annual installments beginning November 12, 2026.
Following the transaction, beneficial ownership is reported as 1,008,235 shares direct and indirect holdings of 748,299 via Folco Development Corp., 236,011 via Foley Family Charitable Foundation, and 2,849,803 via Foley Family Enterprises LLC.
Cannae Holdings (CNNE) reported a director equity grant on a Form 4. On 11/12/2025, the reporting person acquired 23,453 shares of common stock at $0, identified as a grant of restricted stock.
Following the transaction, the director beneficially owns 62,356 shares, held directly. The grant vests in three equal annual installments beginning November 12, 2026.
FAQ
What is the current stock price of Cannae Holdings (CNNE)?
What is the market cap of Cannae Holdings (CNNE)?
